Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:SRNE’

James Flynn Deerfield Management

Sorrentto Therapeutics Inc (SRNE): Are Hedge Funds Right About This Stock?

Is Sorrentto Therapeutics Inc (NASDAQ:SRNE) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours......(read more)
Phongphan/Shutterstock.com

33 Fresh Stories To Inform You About The Financial Markets Today

1. U.S. Stock Market:   “U.S. stocks rallied Monday, with major indexes advancing more than 1% in a broad rally after a strong showing by centrist......(read more)
16 Cities with the Highest Crime Rates in the World

Proposed Stock Offering Sinks Sorrento Therapeutics Inc (SRNE)

Shares of Sorrento Therapeutics Inc (NASDAQ:SRNE) have fallen 22% in extended-market trading after the biopharmaceutical company announced a proposed......(read more)
apple-inc-508812_1280

Jump in Insider Buying at Macquarie Infrastructure after Hedgeye Recommends Shorting the Stock, Spontaneous Insider Sale at Apple Inc. (AAPL), Plus Other Insider Trading

Insider trading behavior should constitute an important piece of data in one’s security analysis process, as past research shows that insider actions......(read more)
cell, stem, research, cold, liquid, nitrogen, medical, test, experiment, clothing, protective, artificial, white, temperature, laboratory, freeze, cryopreservation, samples,

Sorrento Therapeutics Inc. (SRNE): Wildcat Capital Management Growing Impatient With Lack of Disclosure, Repeats Demands

We reported recently that Leonard A. Potter‘s Wildcat Capital Management had sent a letter to the board of Sorrento Therapeutics Inc. (NASDAQ......(read more)
people, person, lab, nuclear, hydrogen, concept, chemistry, technicians, researching, formula, chemists, biotechnology, researchers, discovery, weapon, samples,

Sorrento Therapeutics Inc. (SRNE): Wildcat Capital Management Files a Complaint

According to a newly-amended 13D filing with the US SEC,  Leonard A. Potter’s Wildcat Capital Management LLC, on behalf of  Sorrento Therapeutics......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Sorrento Therapeutics Inc. (SRNE): Wildcat Capital Management Ups Its Stake and Reiterates Demands

A newly amended 13D filing with the US SEC revealed that Leonard A. Potter’s Wildcat Capital Management LLC has sent a new letter to the board of ......(read more)
GREENLIGHT CAPITAL

Billionaire Einhorn Loses Faith in Sunedison Inc. (SUNE), Daniel Och Discloses Stake in Promising Square Inc. (SQ), Plus 2 Other Moves

Quarterly 13F filings are now flowing in for the first quarter reporting period, disclosing the most noteworthy moves made by widely-followed hedge fund......(read more)
Wall Street Bull

Why Are Investors Piling Into These Five Stocks Today?

At a time when the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) is in the red and the forward month WTI contract is well in the green, shares......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

Is Sorrentto Therapeutics Inc (SRNE) A Good Stock To Buy?

Before we spend days researching a stock idea we’d like to take a look at how hedge funds and billionaire investors recently traded that stock.......(read more)
arrow, data, up, rising

Why MeetMe Inc (MEET), La Jolla Pharmaceutical Co. (LJPC), & Sorrento Therapeutics Inc (SRNE) Surged Last Week

MeetMe Inc (NASDAQ:MEET), La Jolla Pharmaceutical Co. (NASDAQ:LJPC), and Sorrento Therapeutics Inc (NASDAQ:SRNE) experienced a formidable surge on the......(read more)
Broadfin Kevin Kotler

Alere Inc (ALR), Lion Biotech (LBIO), Genocea Biosciences Inc (GNCA), Advaxis Inc (ADXS) Among Broadfin’s Top New Health Picks

Broadfin Capital, LLC is a New York-based hedge fund, whose $1.28-billion equity portfolio is invested in healthcare companies. Kevin Kotler, a University......(read more)